Omada Health Inc (OMDA)

NASD · Healthcare · Health Information Services · USA

Omada Health Inc is a small cap company (market value between $300 million and $2 billion) in the Health Information Services industry.

Omada Health delivers virtual care programs for chronic conditions and musculoskeletal issues through dedicated care teams and technology tools. The company serves employers, health plans, and other entities offering cardiometabolic programs for diabetes, hypertension, and weight management, along with musculoskeletal and medication support. Its platform connects members with health coaches, specialists, and connected devices for personalized between-visit care.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Omada Health Inc stock.

Our verdict on OMDA

Not valued: We cannot value this company yet.

We do not publish a value for this company: its filings cover three fiscal years and projecting growth needs four in a row.

ETFs with the most weight in OMDA

17 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Health Information Services

All 40 Health Information Services stocks

Cheaper than OMDA in Health Information Services

13 more in this industry show a wider margin of safety.

Is OMDA undervalued or overvalued?

We do not publish a verdict on OMDA yet. A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.

What is the intrinsic value of OMDA?

We do not publish one (as of the 2026-11-17 close). A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.